Clinical Trial Detail

NCT ID NCT03652545
Title Multi-antigen T Cell Infusion Against Neuro-oncologic Disease (REMIND)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Catherine Bollard
Indications

medulloblastoma

brain stem glioma

choroid plexus carcinoma

central nervous system embryonal carcinoma

malignant glioma

central nervous system cancer

malignant ependymoma

Therapies

MultiTAA-specific T cells

Age Groups: child senior adult

No variant requirements are available.